{
    "pmid": "41456264",
    "title": "Characterization of COVID-19 patients in clinical, epidemiological, and laboratory settings: the role of vitamin D binding protein and vitamin D level in severity.",
    "abstract": "There are contradictory findings on the role of vitamin D-binding protein in COVID-19 development, disease severity, and outcomes. Therefore, we aimed to explore the association between the serum vitamin D level, DBP, and the COVID-19 severity and outcomes. In this cross-sectional study, we observed the suspected and confirmed admitted patients with COVID-19 for the possible outcomes after measurements of vitamin D, vitamin D binding protein (DBP). The study included patients with a mean age of 70.89 years (range: 28-99), mostly aged â‰¥60 years (84.81%) and male (54.43%). Most were admitted to medical wards (60.76%) or ICU (39.24%). The majority had confirmed COVID-19 (81.01%), while 12.66% were not diagnosed. Hospitalization duration varied: 1-3 days (21.52%), 4-7 (17.72%), 8-14 (37.97%), and >14 days (22.78%). Outcomes: 53.16% died, 34.18% discharged, 12.66% recovered. Disease severity was critical (41.77%), severe (30.38%), moderate (24.05%), and mild (3.80%). All received oxygen: 56.96% via reservoir mask, 36.71% continuous positive airway pressure (CPAP), and 6.33% nasal mask. Common comorbidities: hypertension (67.09%), diabetes (37.97%), ischemic heart disease (IHD) (25.32%), and smoking (21.52%). Symptoms: shortness of breath (77.22%), cough (75.95%), chest pain (60.76%). Fever types: persistent (44.59%) and high (27.03%). Only 25.32% were vaccinated (Pfizer 45%, AstraZeneca 30%, Sinopharm 25%), mostly with two doses (85%). Vitamin D was low (16.88). DBP protein (mean: 5.51, range: 0.15-25.20) showed no significant differences across outcomes or severity (p > 0.05). Our study's results, particularly the exceptionally low mean DBP value in a cohort with high COVID-19 severity and mortality, highlight a crucial area of investigation.",
    "disease": "hypertension",
    "clean_text": "characterization of covid patients in clinical epidemiological and laboratory settings the role of vitamin d binding protein and vitamin d level in severity there are contradictory findings on the role of vitamin d binding protein in covid development disease severity and outcomes therefore we aimed to explore the association between the serum vitamin d level dbp and the covid severity and outcomes in this cross sectional study we observed the suspected and confirmed admitted patients with covid for the possible outcomes after measurements of vitamin d vitamin d binding protein dbp the study included patients with a mean age of years range mostly aged years and male most were admitted to medical wards or icu the majority had confirmed covid while were not diagnosed hospitalization duration varied days and days outcomes died discharged recovered disease severity was critical severe moderate and mild all received oxygen via reservoir mask continuous positive airway pressure cpap and nasal mask common comorbidities hypertension diabetes ischemic heart disease ihd and smoking symptoms shortness of breath cough chest pain fever types persistent and high only were vaccinated pfizer astrazeneca sinopharm mostly with two doses vitamin d was low dbp protein mean range showed no significant differences across outcomes or severity p our study s results particularly the exceptionally low mean dbp value in a cohort with high covid severity and mortality highlight a crucial area of investigation"
}